Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2018 1
2019 1
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.
Armstrong A, Fahrbach K, Leonardi C, Augustin M, Neupane B, Kazmierska P, Betts M, Freitag A, Kiri S, Taieb V, Slim M, Gomez NN, Warren RB. Armstrong A, et al. Among authors: kiri s. Dermatol Ther (Heidelb). 2022 Aug;12(8):1777-1792. doi: 10.1007/s13555-022-00760-8. Epub 2022 Jul 7. Dermatol Ther (Heidelb). 2022. PMID: 35798920 Free PMC article.
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons.
Akkoç N, Arteaga CH, Auteri SE, Betts M, Fahrbach K, Kim M, Kiri S, Neupane B, Gaffney K, Mease PJ. Akkoç N, et al. Among authors: kiri s. Rheumatol Ther. 2023 Apr;10(2):307-327. doi: 10.1007/s40744-022-00522-0. Epub 2023 Jan 12. Rheumatol Ther. 2023. PMID: 36633815 Free PMC article. Review.
Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis.
Tillett W, Coates LC, Kiri S, Taieb V, Willems D, Mease PJ. Tillett W, et al. Among authors: kiri s. Ther Adv Musculoskelet Dis. 2022 Dec 13;14:1759720X221140846. doi: 10.1177/1759720X221140846. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 36533099 Free PMC article.
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK.
Schweikert B, Malmberg C, Åkerborg Ö, Kumar G, Nott D, Kiri S, Sapin C, Hartz S. Schweikert B, et al. Among authors: kiri s. Pharmacoecon Open. 2020 Dec;4(4):635-648. doi: 10.1007/s41669-020-00202-1. Pharmacoecon Open. 2020. PMID: 32166657 Free PMC article.